Covered recipient · General Payments record

KENNETH MASHBURN

Allopathic & Osteopathic Physicians Family Medicine

NPI: 1578524369
CMS profile: 464996
Location: HARTSELLE, AL

General Payments · PY2019–2025

$8,592.04

Reported across 492 records
CMS publication 2026-06-30

Latest program year · PY2025

$993.64

54 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated

The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2025 · sorted by reported total

Nature of payment	Amount	Records
Food and Beverage	$993.64	54

By paying entity

PY2025 · sorted by reported total

Paying entity	Amount	Records
Novo Nordisk AS	$196.85	10
Acerta Pharma LLC	$136.72	7
ITI, Inc.	$122.13	5
Boehringer Ingelheim Pharmaceuticals, Inc.	$94.29	6
Lilly USA, LLC	$89.62	5
Exact Sciences Corporation	$62.43	3
PFIZER INC.	$52.12	2
Astellas Pharma US Inc	$42.76	2
Amgen Inc.	$39.40	2
DEXCOM, INC.	$34.95	2
Otsuka America Pharmaceutical, Inc.	$28.17	2
GlaxoSmithKline, LLC.	$25.83	1
SHIELD THERAPEUTICS INC	$25.31	1
Axsome Therapeutics, Inc.	$23.77	1
Corium, Inc.	$19.29	5

By program year

All program years on this page · sorted by year

Program year	Amount	Records
PY2019	$1,515.97	76
PY2020	$1,718.43	97
PY2021	$1,443.02	89
PY2022	$1,175.18	74
PY2023	$861.19	52
PY2024	$884.61	50
PY2025	$993.64	54

Payment records · PY2025 (54)

Sorted by paying entity, then date · as published by CMS

Program year 2025 2019 2020 2021 2022 2023 2024 Record-level detail is published for PY2025; earlier years are summarised in “By program year”.

Paying entity	Amount	Date	Nature of payment	Dispute status	Published	Record ID	Source
Amgen Inc.	$19.70	05/13/2025	Food and Beverage	Undisputed	06/30/2026	1228257696	CMS
Amgen Inc.	$19.70	11/10/2025	Food and Beverage	Undisputed	06/30/2026	1228257694	CMS
Astellas Pharma US Inc	$15.63	02/13/2025	Food and Beverage	Undisputed	06/30/2026	1238743456	CMS
Astellas Pharma US Inc	$27.13	05/28/2025	Food and Beverage	Undisputed	06/30/2026	1238796763	CMS
AstraZeneca Pharmaceuticals LP	$18.43	02/04/2025	Food and Beverage	Undisputed	06/30/2026	1207171237	CMS
AstraZeneca Pharmaceuticals LP	$21.89	03/10/2025	Food and Beverage	Undisputed	06/30/2026	1207312302	CMS
AstraZeneca Pharmaceuticals LP	$13.47	04/24/2025	Food and Beverage	Undisputed	06/30/2026	1206633523	CMS
AstraZeneca Pharmaceuticals LP	$22.88	06/04/2025	Food and Beverage	Undisputed	06/30/2026	1206861499	CMS
AstraZeneca Pharmaceuticals LP	$16.62	07/14/2025	Food and Beverage	Undisputed	06/30/2026	1207223297	CMS
AstraZeneca Pharmaceuticals LP	$23.69	07/21/2025	Food and Beverage	Undisputed	06/30/2026	1206387088	CMS
AstraZeneca Pharmaceuticals LP	$19.74	09/23/2025	Food and Beverage	Undisputed	06/30/2026	1206594952	CMS
Axsome Therapeutics, Inc.	$23.77	11/14/2025	Food and Beverage	Undisputed	06/30/2026	1235593975	CMS
Boehringer Ingelheim Pharmaceuticals, Inc.	$13.74	01/07/2025	Food and Beverage	Undisputed	06/30/2026	1222876831	CMS
Boehringer Ingelheim Pharmaceuticals, Inc.	$17.03	04/08/2025	Food and Beverage	Undisputed	06/30/2026	1222876828	CMS
Boehringer Ingelheim Pharmaceuticals, Inc.	$14.95	05/06/2025	Food and Beverage	Undisputed	06/30/2026	1222876835	CMS
Boehringer Ingelheim Pharmaceuticals, Inc.	$17.03	07/01/2025	Food and Beverage	Undisputed	06/30/2026	1222876838	CMS
Boehringer Ingelheim Pharmaceuticals, Inc.	$17.03	09/09/2025	Food and Beverage	Undisputed	06/30/2026	1222876843	CMS
Boehringer Ingelheim Pharmaceuticals, Inc.	$14.51	11/06/2025	Food and Beverage	Undisputed	06/30/2026	1222876847	CMS
Corium, LLC	$2.89	02/06/2025	Food and Beverage	Undisputed	06/30/2026	1185767081	CMS
Corium, LLC	$3.72	03/06/2025	Food and Beverage	Undisputed	06/30/2026	1185768269	CMS
Corium, LLC	$5.30	05/21/2025	Food and Beverage	Undisputed	06/30/2026	1185770874	CMS
Corium, LLC	$3.27	08/14/2025	Food and Beverage	Undisputed	06/30/2026	1185767689	CMS
Corium, LLC	$4.11	10/23/2025	Food and Beverage	Undisputed	06/30/2026	1185768861	CMS
Dexcom, Inc.	$16.75	07/10/2025	Food and Beverage	Undisputed	06/30/2026	1250499612	CMS
Dexcom, Inc.	$18.20	08/26/2025	Food and Beverage	Undisputed	06/30/2026	1250499614	CMS
Exact Sciences Corporation	$21.92	01/22/2025	Food and Beverage	Undisputed	06/30/2026	1235307233	CMS
Exact Sciences Corporation	$19.55	03/31/2025	Food and Beverage	Undisputed	06/30/2026	1235307237	CMS
Exact Sciences Corporation	$20.96	07/29/2025	Food and Beverage	Undisputed	06/30/2026	1235307254	CMS
GlaxoSmithKline, LLC.	$25.83	07/17/2025	Food and Beverage	Undisputed	06/30/2026	1190668624	CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)	$26.33	04/28/2025	Food and Beverage	Undisputed	06/30/2026	1241360847	CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)	$23.94	05/08/2025	Food and Beverage	Undisputed	06/30/2026	1241360849	CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)	$22.71	06/30/2025	Food and Beverage	Undisputed	06/30/2026	1241360851	CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)	$30.11	09/11/2025	Food and Beverage	Undisputed	06/30/2026	1241360853	CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)	$19.04	10/22/2025	Food and Beverage	Undisputed	06/30/2026	1241360855	CMS
Lilly USA, LLC	$24.16	04/30/2025	Food and Beverage	Undisputed	06/30/2026	1186677285	CMS
Lilly USA, LLC	$21.24	05/19/2025	Food and Beverage	Undisputed	06/30/2026	1186709837	CMS
Lilly USA, LLC	$15.23	06/03/2025	Food and Beverage	Undisputed	06/30/2026	1186677281	CMS
Lilly USA, LLC	$13.82	06/11/2025	Food and Beverage	Undisputed	06/30/2026	1186728079	CMS
Lilly USA, LLC	$15.17	07/15/2025	Food and Beverage	Undisputed	06/30/2026	1186677283	CMS
Novo Nordisk Inc	$6.14	01/09/2025	Food and Beverage	Undisputed	06/30/2026	1188430315	CMS
Novo Nordisk Inc	$21.90	02/06/2025	Food and Beverage	Undisputed	06/30/2026	1188146923	CMS
Novo Nordisk Inc	$23.69	02/27/2025	Food and Beverage	Undisputed	06/30/2026	1188361432	CMS
Novo Nordisk Inc	$21.90	04/17/2025	Food and Beverage	Undisputed	06/30/2026	1188740784	CMS
Novo Nordisk Inc	$20.44	04/21/2025	Food and Beverage	Undisputed	06/30/2026	1188557661	CMS
Novo Nordisk Inc	$21.89	05/14/2025	Food and Beverage	Undisputed	06/30/2026	1188149164	CMS
Novo Nordisk Inc	$21.26	06/10/2025	Food and Beverage	Undisputed	06/30/2026	1188421323	CMS
Novo Nordisk Inc	$20.44	08/12/2025	Food and Beverage	Undisputed	06/30/2026	1188794508	CMS
Novo Nordisk Inc	$19.25	09/04/2025	Food and Beverage	Undisputed	06/30/2026	1188684929	CMS
Novo Nordisk Inc	$19.94	10/09/2025	Food and Beverage	Undisputed	06/30/2026	1188190482	CMS
Otsuka America Pharmaceutical, Inc.	$13.68	06/10/2025	Food and Beverage	Undisputed	06/30/2026	1227405639	CMS
Otsuka America Pharmaceutical, Inc.	$14.49	06/24/2025	Food and Beverage	Undisputed	06/30/2026	1227405642	CMS
PFIZER INC.	$21.24	03/04/2025	Food and Beverage	Undisputed	06/30/2026	1228892801	CMS
PFIZER INC.	$30.88	08/14/2025	Food and Beverage	Undisputed	06/30/2026	1229481130	CMS
SHIELD THERAPEUTICS INC	$25.31	10/02/2025	Food and Beverage	Undisputed	06/30/2026	1249626055	CMS

Source & provenance

Dataset: CMS Open Payments — General Payments
Publisher of source data: Centers for Medicare & Medicaid Services
CMS publication date: 2026-06-30
Program years on this page: 2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files: Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
Generated from: OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.